Literature DB >> 32244067

β-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC.

Lingmin Huang1, Ruiheng Luo1, Jing Li1, Dan Wang2, Yening Zhang1, Liping Liu3, Ningjie Zhang4, Xueming Xu1, Ben Lu5, Kai Zhao6.   

Abstract

NLRP3 (NOD-, LRR- and pyrin domain- containing protein 3) inflammasome is involved in diverse inflammatory diseases, so the activation of NLRP3 inflammasome needs to be tightly regulated to prevent excessive inflammation. However, the endogenous regulatory mechanisms of NLRP3 inflammasome are still less defined. Here, we report that β-catenin, which is the central mediator of the canonical Wnt/β-catenin signaling, promotes NLRP3 inflammasome activation. When we suppressed the expression of β-catenin by siRNA or pharmacological inhibitor, the NLRP3 inflammasome activation was impaired. Accordingly, β-catenin inhibitor attenuated LPS-induced systemic inflammation in vivo. Mechanistically, we found β-catenin interacted with NLRP3 and promoted the association between NLRP3 and ASC. Thus, our study revealed a novel role of β-catenin in NLRP3 inflammasome activation and suggest an endogenous crosstalk between Wnt/β-catenin signal and NLRP3 inflammasome.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interleukin-1β; NLRP3 inflammasome; XAV-939; β-catenin

Year:  2020        PMID: 32244067     DOI: 10.1016/j.molimm.2020.02.017

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  The β-catenin/CBP signaling axis participates in sepsis-induced inflammatory lung injury.

Authors:  Xia Cheng; Dandan Liu; Xinxin Ren; You Nie; Yibing Zhao; Ruyu Chen; Hongwei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

Review 2.  SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review.

Authors:  Ping Jiang; Kai Wei; Cen Chang; Jianan Zhao; Runrun Zhang; Lingxia Xu; Yehua Jin; Linshuai Xu; Yiming Shi; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 3.  Pyroptosis and Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Implications.

Authors:  Yuying Ge; Yuying Chen; Chijiao Guo; Huan Luo; Fangda Fu; Weifeng Ji; Chengliang Wu; Hongfeng Ruan
Journal:  J Inflamm Res       Date:  2022-10-17

Review 4.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

Review 5.  Lysolipids in Vascular Development, Biology, and Disease.

Authors:  Eric Engelbrecht; Calum A MacRae; Timothy Hla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

6.  VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients.

Authors:  Sara Rezzola; Jessica Guerra; Adwaid Manu Krishna Chandran; Alessandra Loda; Anna Cancarini; Piergiuseppe Sacristani; Francesco Semeraro; Marco Presta
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

7.  C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome.

Authors:  Xueming Xu; Jing Li; Xiuyan Long; Sifan Tao; Xiaoyu Yu; Xixian Ruan; Kai Zhao; Li Tian
Journal:  Front Pharmacol       Date:  2021-07-12       Impact factor: 5.810

Review 8.  The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.

Authors:  Natasha Irrera; Massimo Russo; Giovanni Pallio; Alessandra Bitto; Federica Mannino; Letteria Minutoli; Domenica Altavilla; Francesco Squadrito
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

Review 9.  Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks.

Authors:  Ting-Yi Lin; Meng-Chun Tsai; Wei Tu; Hsin-Chih Yeh; Shu-Chi Wang; Shu-Pin Huang; Chia-Yang Li
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

Review 10.  The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification.

Authors:  Chenyang Yu; Caihua Zhang; Zhihui Kuang; Qiang Zheng
Journal:  Inflammation       Date:  2020-11-20       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.